Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

April 12, 2005; 64 (7) Articles

Cellular telephones and risk for brain tumors

A population-based, incident case-control study

H. Collatz Christensen, J. Schüz, M. Kosteljanetz, H. Skovgaard Poulsen, J. D. Boice, J. K. McLaughlin, C. Johansen
First published April 11, 2005, DOI: https://doi.org/10.1212/01.WNL.0000156351.72313.D3
H. Collatz Christensen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Schüz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kosteljanetz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Skovgaard Poulsen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. D. Boice Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. K. McLaughlin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Johansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Cellular telephones and risk for brain tumors
A population-based, incident case-control study
H. Collatz Christensen, J. Schüz, M. Kosteljanetz, H. Skovgaard Poulsen, J. D. Boice, J. K. McLaughlin, C. Johansen
Neurology Apr 2005, 64 (7) 1189-1195; DOI: 10.1212/01.WNL.0000156351.72313.D3

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
1209

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Objective: To evaluate a possible association of glioma or meningioma with use of cellular telephones, using a nationwide population-based case-control study of incident cases of meningioma and glioma.

Methods: The authors ascertained all incident cases of glioma and meningioma diagnosed in Denmark between September 1, 2000, and August 31, 2002. They enrolled 252 persons with glioma and 175 persons with meningioma aged 20 to 69. The authors also enrolled 822 randomly sampled, population-based controls matched for age and sex. Information was obtained from personal interviews, medical records containing diagnoses, and the results of radiologic examinations. For a small number of cases and controls, the authors obtained the numbers of incoming and outgoing calls. They evaluated the memory of the respondents with the Mini-Mental State Examination and obtained data on socioeconomic factors from Statistics Denmark.

Results: There were no material socioeconomic differences between cases and controls or participants and non-participants. Use of cellular telephone was associated with a low risk for high-grade glioma (OR, 0.58; 95% CI, 0.37 to 0.90). The risk estimates were closer to unity for low-grade glioma (1.08; 0.58 to 2.00) and meningioma (1.00; 0.54 to 1.28).

Conclusion: The results do not support an association between use of cellular telephones and risk for glioma or meningioma.

Little is known about the risk factors for tumors of the brain.1 Although some attention has been given to the radiofrequency fields emitted from cellular telephones, the fact that they do not have enough energy to break chemical bonds or damage DNA2 raises doubt that they could cause cancer.3,4 As radiofrequency fields are unlikely to cause gene mutations, the proposed biologic process underlying a possible association between use of cellular telephones and the risk for cancer is a thermal or a non-thermal mechanism that promotes tumor growth.5–7 Of the epidemiologic studies of tumors of the brain and radiofrequency fields from cellular telephones,4,8–11 only one showed a significantly increased risk for tumors after long-term use of cellular telephones or cordless telephones.12–15 The latter studies have, however, been criticized on a number of methodologic bases.16–18

We report here the results of the Danish component of the Interphone project, which was initiated as an international incident case-control study of glioma, meningioma, parotid gland tumors, and acoustic neuroma with a common protocol in 13 countries.19 We recently published our results on the risk for acoustic neuroma11; here, we report patterns of cellular telephone use among 252 persons with gliomas and 175 with meningioma20 and 822 randomly sampled, population-based control persons. Tumors are differentiated into gliomas and meningiomas on the basis of their origin in two different intracranial tissues; they are thus regarded as two different diseases. The ratio of the two tumor types among our cases was similar to those in previous studies based on data from the Danish Cancer Register.21

Methods.

Glioma (all grades).

In Denmark, diagnoses of glioma (International Classification of Diseases topography codes 191.0–191.9 and morphology codes 93803–94603) are confirmed by MRI, CT, or histologic review. Persons suspected of having glioma were referred to one of the five neurosurgical departments in Denmark, and one surgeon at each department reviewed all incoming cases and notified our study nurse when an eligible patient had been admitted. The study nurse or a specially trained medical student would then approach the patient for a face-to-face interview.

We identified 464 potential incident cases of glioma in persons aged 20 to 69 years who had been referred to these departments between September 1, 2000, and August 31, 2002. All cases were checked against the Danish Cancer Register22 to determine whether they were cancer-free before the date of diagnosis of the glioma, to ensure that no bias was introduced by a previously diagnosed cancer. As a result, 54 cases with prior cancer, other than non-melanoma skin cancer, were excluded. A further 44 persons were excluded because the diagnosis was found to be incorrect on histologic review, 10 were excluded because the cases were prevalent or because they were over 69 years of age at diagnosis, and 2 persons were excluded because they did not understand Danish sufficiently. Of the 354 eligible persons with glioma, 38 (11%) refused to participate, a further 32 (9%) died before interview (with no proxy available), and 32 (9%) were aphatic, partially paralyzed, or severely depressed, leaving 252 (71%) persons for interview. The diagnoses of all 252 glioma cases were confirmed by histologic examination. They comprised 171 high-grade gliomas (WHO grade III-IV) and 81 low-grade gliomas (WHO grade II). For 19 patients, the interviews were conducted with a proxy (usually the spouse or child) 3 to 6 months after the death of the patient.

The potential exposure of the patients to radiofrequency energy from cellular telephones was estimated as high, medium, or low from the anatomic location of the glioma. The most energy is absorbed by the tissues closest to the position of the telephone against the head, and absorption drops off considerably at a depth of 4 to 5 cm.23 If exposure to radiofrequency fields were associated with the occurrence of brain tumors, a shift in tumor location from areas of low exposure to those of high exposure would be expected among regular cellular telephone users.

Meningioma.

Diagnoses of meningioma (International Classification of Diseases topography code 192.1 and morphology codes 95300–95393) were confirmed in the same way as for glioma. Surgery for meningioma is, however, performed later after diagnosis than for glioma, so histologic confirmation of the diagnoses took longer. We identified 291 reported cases of meningioma, which were checked at ascertainment with the Cancer Register22 to determine whether they were cancer-free before diagnosis, and 30 cases with a prior diagnosis of cancer, excluding non-melanoma skin cancer, were excluded. Of the total of 261 reported incident cases of meningioma, all except 8 (3%) were confirmed by histologic examination, except those that were diagnosed by either MRI or CT. We excluded 10 cases with an incorrect diagnosis, 8 prevalent cases or in persons aged over 69 years at diagnosis, and 5 persons who did not understand Danish sufficiently, leaving 238 eligible meningioma cases. Of the eligible patients, 35 (15%) declined to participate (mostly because of poor physical condition), 11 (5%) died before we could approach them, and 10 (4%) were too debilitated to complete an interview; 7 (3%) were not approached because they had not been informed sufficiently about their diagnosis, leaving 175 (74%) cases of meningioma. Three interviews were conducted with proxies.

Controls.

We selected one control person for each reported brain tumor case, frequency matched on age (within 5-year ranges) and sex. The control persons were population based and sampled randomly from the Danish Central Population Register. Like the cases, the controls were checked against the Danish Cancer Register22 to exclude any with a prior diagnosis of cancer. At the end of the study period, we found that we had interviewed more controls than cases; however, all the controls were used in the analysis. By post hoc matching on sex and age (5-year intervals), we gave each control person a reference date, which was the date of diagnosis of the corresponding case. The response rate was 64% (n = 822).

Interviews.

As part of the Interphone study, a computerized personal questionnaire was developed.19 Face-to-face interviews were conducted either by a study nurse or by a specially trained medical student, either at home after surgery or at the bedside in hospital before surgery. Respondents were asked if they had ever used a cellular telephone. If so, they were asked if they were regular users (use at least once a week for 6 months or more) and how many different cellular telephones they had used regularly. For each cellular telephone used regularly, start and stop dates of use were recorded. If the respondent was still using the cellular telephone on the day of the interview, the stop date was set at the date of diagnosis (for cases) or the reference date (for controls).

The questionnaire also contained questions on the numbers of calls made and received and on the duration of calls on each cellular telephone used by the respondent, and changes in pattern of use over more than 6 months. On the basis of this information, we estimated the lifetime number of calls and the lifetime hours of telephone use. For each cellular telephone, we obtained information on use of handsets with a microphone and use of hand-free sets in vehicles. This information was used to modify the exposure estimate (see below).

Tumor characteristics.

For all cases, clinical data were obtained from medical records to verify the diagnosis, calculate the tumor size, and determine its location. We used imaging reports and to some extent actual images to determine the locations of the tumors. Gliomas were assigned to the lobe of the brain in which most of the tumor tissue was located. We considered that the lobes with high exposure are the temporal and parietal lobes, those with medium exposure are the frontal and occipital lobes, and that the remaining part of the central area of the brain has low exposure. The location of meningiomas that indented the brain in the midline or above the hemispheres was assigned according to the lobe they indented. Cases in which this distinction could not be established were categorized as laterally or centrally located. The area of the brain defined as lateral was all that located laterally of an arbitrary vertical cranio-sacral line drawn through the orbit and posterially (figure).

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure. Cerebral CT scan of a brain showing the areas described as lateral and central.

Socioeconomic status.

For all patients and controls, we obtained information on socioeconomic status, including level of education, marital status, employment, income in the year 2001, and wealth defined as taxable assets in 2001 from the Intergraded Database for Labor Market Research at Statistics Denmark.24 As this information was provided in an anonymous form, it could not be adjusted for in the logistic regression models (see below). Furthermore, the linkage between our data and the socioeconomic data from Statistics Denmark did not enable us to stratify by diagnosis (low-grade glioma, high-grade glioma, meningioma). It did allow us to compare the socioeconomic characteristics of cases and controls and study participants and non-participants.

Recall.

Recall bias is a serious threat to the results obtained in case-control studies and especially in studies of persons with serious brain diseases. For all patients and controls, we obtained detailed information about the frequency and duration of use of the most recent reported cellular telephone from the two largest cellular telephone network operators in Denmark. This information was compared with the data on the questionnaire in order to validate the information obtained during interview. We provided the operators with all the cellular telephone numbers that had been reported during interviews, and a search of the electronic files of the two providers gave information on incoming and outgoing calls for 27 patients and 47 controls. Periods and patterns of cellular telephone use reported on the questionnaire were compared with equivalent data provided by the operators to identify periods for which we had information from both sources. Subsequently, we compared the number and duration of calls from the two sources.

We also evaluated the recall of both cases and control persons by asking them to complete the Folstein Mini-Mental State Examination, which is a short, well-validated test of memory.25

The best-established risk factor for tumors of the brain is high-dose ionizing radiation. We estimated the risk for meningioma, low-grade glioma, or high-grade glioma after exposure to five levels of ionizing radiation: 0 = baseline; 1 = up to five diagnostic radiologic examinations of the skull more than 2 years before diagnosis; 2 = one or more CT scans of the skull more than 2 years before diagnosis or more than five radiologic examinations of the skull more than 2 years before diagnosis; 3 = occupational exposure, as defined by UNSCEAR,26 for more than 5 years and more than 2 years before diagnosis; 4 = radiation therapy more than 2 years before diagnosis.

Ethical approval.

Approval was obtained from the Danish Ethical Committee (jr. no. KF 01-105/00) and the Danish Data Protection Agency (jr. no. 2000-1200-268 and 2001-41-1290). Written material was produced in accordance with the Helsinki II Declaration. Signed informed consent forms were collected from each case and control person and saved for documentation.

Statistical analysis.

Unconditional logistic regression models for frequency-matched data sets were used to estimate the OR and its respective 95% CI (Proc Phreg in SAS 8, Reference). All analyses were stratified for sex and 5-year age groups and additionally adjusted for educational level (low, intermediate, high; see table 1), region of residence (eastern Denmark, Funen, and western Denmark; see table 1), marital status (married vs single, divorced, or widowed). We defined the following exposure metrics: being a regular cellular telephone user (yes, no), years since first regular cellular telephone use, lifetime number of calls, lifetime hours of use, hours of use in the interval between first regular use and 5 years before the reference date, and intensity of use, defined as lifetime hours of use divided by duration of use. Cumulative use of cellular telephones was modified according to use of hand-free sets by a factor that varied with the answers given. We reduced the exposure by 100% according to whether the respondents reported use of hand-free devices all the time, most of the time (75% reduction), half the time (50% reduction), or less than half the time (25% reduction). The cumulative use was multiplied by the modification factor for the periods when hand-free devices were used. The cut-off points used in table 2 were defined in advance of the conduct of the analyses. For the three cumulative measures, the cut-off points are based on the distribution among the combined controls. The median of this distribution was chosen as the first cut-off point (50% percentile) and the third quartile (75% percentile) as the second cut-off point, leading to a baseline category of non-regular users and three exposure categories. Proxy interviews were excluded from all analysis including information on number or duration of calls.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1 Characteristics of participants and nonparticipants in the Danish case-control study of cellular telephones and risk for brain tumors

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 2 Risk analyses in a Danish case-control study of cellular telephone use and the risk for brain tumors

The sizes of tumors in regular cellular phone users were compared with those of non-regular users with the Wilcoxon test. To evaluate whether the distribution of tumor locations differed between regular and non-regular cellular phone users, we used the χ2 test for univariate analysis and categorical data, modeling for ordinally scaled data (exposure areas in the brain, as described above), using weighted least squares estimates for cellular phone use and for age and sex as additional independent variables.

The agreement between the cellular telephone use derived from the questionnaire and that derived from the network operators was analyzed with the kappa coefficient on categorized data (both distributions divided into quartiles). The kappa statistic quantifies the extent of agreement beyond what level of agreement is expected by chance alone. Kappa takes values between 1 (perfect agreement), 0 (no agreement), and −1 (perfect disagreement), with values around 0.5 representing fair agreement. Furthermore we had intended to apply limits for agreement,27 but this could not be done because of the small numbers and because of the asymmetry of the data, with a large disagreement among heavy users that did not follow a normal distribution.

Results.

We found no significant differences in socioeconomic characteristics between case and control persons or between participants and non-participants (see table 1). Female controls were significantly more likely than male controls to refuse to participate. The overall analyses did not reveal an increased risk for either glioma or meningioma in relation to no or any regular use of a cellular telephone, frequency of use, time since first use (latency), or various expressions of cumulative use (see table 2). While most of the risk estimates for meningioma and low-grade glioma were close to 1.0, we often observed decreased OR for high-grade gliomas. All gliomas combined were not associated with regular use of cellular telephones (OR, 0.71; 95% CI, 0.50 to 1.01). Adjustment for the potential confounders as described above had only marginal effects on the risk estimates (data not shown).

Exposure to ionizing radiation did not influence the risk estimates (table 3). Cellular telephone users who were also exposed to ionizing radiation were not at increased risk.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 3 Risk analyses for exposure to ionizing radiation and exposure to both ionizing radiation and cellular telephone use in a Danish case-control study of cellular telephone use and risk for brain tumors

In the main analyses, cases were compared only with controls assigned to the same diagnostic group during post hoc matching. A sensitivity analysis in which cases in each diagnostic group were compared with all controls (n = 822) did not change the risk estimates appreciably (data not shown). Further sensitivity analyses in which proxy interviews and persons with poor Mini-Mental State Examination scores were excluded and stratification rather than adjustment was conducted for educational level revealed an OR closer to 1.0 for high-grade glioma (OR = 0.71; 95% CI, 0.38 to 1.32, for regular phone use).

Information on tumor size was not available for all cases. An overall analysis of the tumor sizes in this study showed that the meningiomas (data on size were available for 146 cases) were on average smaller (median, 40.0 cm3) than the low-grade gliomas (53 cases; median, 47.3 cm3), which, in turn, were on average smaller than the high-grade gliomas (126 cases; median, 57.1 cm3). For regular users the median sizes of the meningiomas were 31.5 cm3, low-grade gliomas were 42.0 cm3, and high-grade gliomas were 57.1 cm3. For non-users the median sizes for meningiomas were 45.0 cm3, for low-grade gliomas 90.0 cm3, and high-grade gliomas were 57.4 cm3 (Wilcoxon test, p = 0.21, 0.13, 0.49). The risk for developing a larger brain tumor (median volume of all tumors combined, ≥46.3 cm3) was 0.77 (95% CI, 0.52 to 1.14) for regular users of cellular telephones when compared with non-users or rare users.

When the locations of the gliomas were divided according to exposure, 47% of the tumors in non-regular users were in the low exposure area, 6% in the medium exposure area, and 47% in the high. Among regular users, the corresponding distribution was 47%, 14%, and 39%, revealing a small deficit of tumors in the high exposure area (χ2 test, p = 0.08). An analysis of weighted least squares estimates including additional potential explanatory factors showed an effect of age on tumor occurrence in the high exposure area (p = 0.03) but no effect of regular cellular telephone use (p = 0.81) or sex (p = 0.67). The fact that older people are less likely to be regular cellular telephone users explains the above-mentioned deficit.

The Mini-Mental State Examination was completed by 80% of the patients and 90% of the control persons. Patients scored significantly lower than the controls. Patients with meningioma or low-grade glioma had similar scores, whereas those with high-grade glioma scored significantly lower (Wilcoxon test, p < 0.01). Most of the failures observed during performing of the test were due to problem in recalling words (aphasia) and problems with writing and drawing due to paralysis.

In the period December 1, 2001, to January 1, 2003, we obtained records of the number and duration of calls (incoming and outgoing) in various periods (mean, 218 days; range, 2 to 444 days) for 27 patients and 47 controls. To compare the data, we calculated a weighted kappa coefficient for categorized data (quartiles). The weighted kappa coefficient was 0.31 (0.24 to 0.38) for patients and 0.28 (0.21 to 0.35) for control persons in regard to number of calls. For hours of calls, the weighted kappa value was close to zero.

Discussion.

Our results are in line with previous tests of this hypothesis, including two large case-control studies in the United States,8,9 a mortality study in the United States,28 and a large cohort incidence study in Denmark.4 In contrast, a Finish conducted register-based case-control10 study of 398 cases of brain cancer and 1990 population-based controls observed significantly increased risks among users of analogue telephones, especially for glioma (OR, 2.1; 95% CI, 1.3 to 3.4), although no analysis of tumor location, i.e., lobe or laterality, was reported. One group in Sweden has performed two prevalent case-control studies12,29 involving 588 and 1,617 cases. In the first study on brain tumors they did not find an increased risk for developing a brain tumor of any type, but in the second study they reported a significantly increased risk for astrocytoma on the side of the head on which the telephone was most frequently held, regardless of telephone type: OR = 1.8 (95% CI, 1.1 to 3.2) for analogue telephones and 1.8 (1.1 to 2.8) for digital telephones. These studies have been criticized for the use of prevalent cases, selection bias, interviewer bias, and unclear reporting of results.16–18

Taken together, the weight of evidence does not indicate that cellular telephones are a risk factor for glioma or meningioma of the brain. Nevertheless, in all the studies the numbers of long-term users and heavy users are limited, obviating any firm conclusion. In our study, few persons reported regular cellular telephone use for 10 years or more.

There is no biologic plausibility for our finding of a decreased risk for high-grade glioma associated with use of cellular telephones. Hence, the possibility of selection bias or recall bias must be addressed. Confounding might play a role if use of cellular telephones is a proxy for a factor associated with a decreased risk for glioma. As knowledge about the etiology of gliomas is limited, there is no obvious lifestyle or environmental factor that would act as a confounder.1

A combination of bias and confounding is another possible explanation. We ascertained almost all cases of glioma and meningioma in Denmark, thus reducing the possibility of selection bias. The relatively low participation might have introduced bias, but the data from Statistics Denmark did not indicate differences in socioeconomic status. We did identify a large number of patients with high-grade glioma who had had a short education, which may explain the low frequency of regular and long-term users in that group. It has been reported that blue-collar workers are more likely to develop high-grade gliomas than white-collar workers.30–33

We addressed the possibility of recall bias in two ways. Our comparison of information on number and duration of calls reported on the questionnaire with information from two telephone network operators for a small number of patients and controls showed that both groups recalled the number of calls well but recalled the duration of the calls imprecisely. A similar trend was seen in a German study on recall ability.31 Nevertheless, the recall of patients was no worse than that of controls. In the Mini-Mental State Examination, patients had a lower average score than controls, and patients with high-grade glioma scored the lowest of all four groups.

Few persons in our study had been exposed to ionizing radiation. As seen in table 3, we found no association between exposure to ionizing radiation and the development of brain tumors. The small number of exposed persons in our study, the relatively low exposure levels, and the relatively advanced age at exposure might explain this result.

The degree of malignancy was reflected in the size of the tumor at diagnosis. The tumors of regular phone users were smaller than those of non-users, and the risk for developing a large tumor was 0.77 for regular users. The size of tumors after exposure to radiofrequency fields has not been reported previously, but one would expect the opposite result should the hypothesis of a tumor-promoting effect of radiofrequency fields exposure hold true.

The locations of the gliomas led us to conclude that location is not associated with use of cellular telephones. We also observed no association between the laterality of meningiomas and cellular telephone use (data not shown). Owing to the small numbers and the low statistical power of analyses on a national level, however, more meaningful results will be obtained at the international level of the Interphone study.

Acknowledgment

The authors thank Lars H. Thomassen for computer assistance.

Footnotes

  • Supported by the European Commission Fifth Framework Program—Quality of life and management of living resources (Contract QLK4-CT1999–01563), a grant from Union Internationale Contre le Cancer (UICC) (RCA/01/08), a grant from the International Epidemiology Institute, Rockville, MD, and the Danish Cancer Society. The UICC received funds for this purpose from the Mobile Manufacturers' Forum and the GSM Association. Provision of funds to the Interphone study investigators via the UICC was governed by agreements that guaranteed Interphone's complete scientific independence.

    Received September 16, 2004. Accepted in final form December 16, 2004.

References

  1. 1.↵
    Preston-Martin S, Mack W. Neoplasms in the nervous system. In: Schottenfeld D, Fraumeni J-FJ, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996;1231–1312.
  2. 2.↵
    Stuchly MA. Biomedical concerns in wireless communications. Crit Rev Biomed Eng 1998;26:117–151.
    OpenUrlPubMed
  3. 3.↵
    Moulder JE, Erdreich LS, Malyapa RS, et al. Cell phones and cancer: what is the evidence for a connection? Radiat Res 1999;151:513–531.
    OpenUrlPubMed
  4. 4.↵
    Johansen C, Boice J, Jr., McLaughlin J, et al. Cellular telephones and cancer—a nationwide cohort study in Denmark. J Natl Cancer Inst 2001;93:203–207.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    Repacholi MH, Basten A, Gebski V, et al. Lymphomas in E mu-Pim1 transgenic mice exposed to pulsed 900 MHZ electromagnetic fields. Radiat Res 1997;147:631–640.
    OpenUrlPubMed
  6. 6.
    Repacholi MH. Radiofrequency field exposure and cancer: what do the laboratory studies suggest? Environ Health Perspect 1997;105 Suppl 6:1565–1568.
  7. 7.
    Steward W. Mobile phones and health. IEGMP, ed. Chilton, Oxon: National Radiological Protection Board, 2000.
  8. 8.↵
    Inskip PD, Tarone RE, Hatch EE, et al. Cellular-telephone use and brain tumors. N Engl J Med 2001;344:79–86.
    OpenUrlCrossRefPubMed
  9. 9.
    Muscat JE, Malkin MG, Thompson S, et al. Handheld cellular telephone use and risk of brain cancer. JAMA 2000;284:3001–3007.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Auvinen A, Hietanen M, Luukkonen R, et al. Brain tumors and salivary gland cancers among cellular telephone users. Epidemiology 2002;13:356–359.
    OpenUrlCrossRefPubMed
  11. 11.↵
    Christensen HC, Schuz J, Kosteljanetz M, et al. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 2004;159:277–283.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    Hardell L, Nasman A, Pahlson A, et al. Use of cellular telephones and the risk for brain tumours: a case-control study. Int J Oncol 1999;15:113–116.
    OpenUrlPubMed
  13. 13.
    Hardell L, Mild KH, Pahlson A, et al. Ionizing radiation, cellular telephones and the risk for brain tumours. Eur J Cancer Prev 2001;10:523–529.
    OpenUrlCrossRefPubMed
  14. 14.
    Hardell L, Mild KH, Carlberg M. Further aspects on cellular and cordless telephones and brain tumours. Int J Oncol 2003;22:399–407.
    OpenUrlPubMed
  15. 15.
    Hardell L, Hallquist A, Mild KH, et al. Cellular and cordless telephones and the risk for brain tumours. Eur J Cancer Prev 2002;11:377–386.
    OpenUrlCrossRefPubMed
  16. 16.↵
    Boice JDJ, McLaughlin JK. Epidemiologic studies of cellular telephones and cancer risk. SSI Report. Swedish Radiation Protection Agency, ed. 16, 0–38. Sweden: Swedish Radiation Protection Agency, 2002.
  17. 17.
    Ahlbom A, Feychting M. Re: Use of cellular phones and the risk of brain tumours: a case-control study. Int J Oncol 1999;15:1045–1047.
    OpenUrlPubMed
  18. 18.
    AGNIR. Health effect from radiofrequency electromagnetic fields. AGNIR 2004;14:1–81.
  19. 19.↵
    Cardis E, Kilkenny M. International case control study of cancers of brain and salivary gland, report of the feasibility study. IARC, ed. Lyon, France: International Agency for Reasearch on Cancer, 1999.
  20. 20.↵
    World Health Organisation. International Classification of Diseases for Oncology (ICD-O). Geneva: World Health Organisation, 1976.
  21. 21.↵
    Christensen HC, Kosteljanetz M, Johansen C. Incidences of gliomas and meningiomas in Denmark, 1943 to 1997. Neurosurgery 2003;52:1327–1334.
    OpenUrlCrossRefPubMed
  22. 22.↵
    Storm HH. The Danish Cancer Registry, a selfreporting national cancer registration system with elements and active data collection. In: Jensen O, Parkin D, Macknnan R, Muir C, Sheet R, eds. Cancer registration principles and methods. Lyon: IARC, 1991;220–236.
  23. 23.↵
    Dimbylow PJ, Mann S. SAR calculations in an anatomically realistic model of the head for mobile communication transceivers at 900 MHz and 1.8 GHz. Phys Med Biol 1994;39:1537–1553.
    OpenUrlCrossRefPubMed
  24. 24.↵
    Statistics Denmark. IDA—an integrated data base for labour market research. Main report. Copenhagen, Denmark: Statistics Denmark, 1991.
  25. 25.↵
    Cockrell JR, Folstein M. Mini-Mental state examination (MMSE). Psychopharmacol Bull 1988;24:689–692.
    OpenUrlPubMed
  26. 26.↵
    UNSCEAR. Sources and effects of ionizing radiation. UNSCEAR reports. UNSCEAR, ed. Geneva: UNSCEAR, 2000.
  27. 27.↵
    Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–310.
  28. 28.↵
    Rothman KJ, Loughlin JE, Funch DP, et al. Overall mortality of cellular telephone customers. Epidemiology 1996;7:303–305.
    OpenUrlPubMed
  29. 29.
    Hardell L, Mild KH, Carlberg M. Case-control study on the use of cellular and cordless phones and the risk for malignant brain tumours. Int J Radiat Biol 2002;78:931–936.
    OpenUrlCrossRefPubMed
  30. 30.↵
    Brownson RC, Reif JS, Chang JC, et al. An analysis of occupational risks for brain cancer. Am J Public Health 1990;80:169–172.
    OpenUrlPubMed
  31. 31.↵
    Kaplan S, Etlin S, Novikov I, et al. Occupational risks for the development of brain tumors. Am J Ind Med 1997;31:15–20.
    OpenUrlCrossRefPubMed
  32. 32.
    Carozza SE, Wrensch M, Miike R, et al. Occupation and adult gliomas. Am J Epidemiol 2000;152:838–846.
    OpenUrlAbstract/FREE Full Text
  33. 33.
    Krishnan G, Felini M, Carozza SE, et al. Occupation and adult gliomas in the San Francisco Bay area. J Occup Environ Med 2003;45:639–647.
    OpenUrlPubMed

Letters: Rapid online correspondence

  • Cellular telephones and risk for brain tumors: A population-based, incident case-control study
    • Brian D. Gale, SUNY Health Sciences Center at Brooklyn, University Hospital of Brooklyn, Box 1208, 450 Clarkson Ave., Brooklyn, NY 11203bgale@downstate.edu
    • David Juran, Ph.D.
    Submitted July 20, 2005
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Topics Discussed

  • All Oncology
  • Primary brain tumor
  • Case control studies

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise